Literature DB >> 10233646

Soluble E-selectin serum levels correlate with disease activity in psoriatic patients.

J Szepietowski1, F Wasik, E Bielicka, P Nockowski, A Noworolska.   

Abstract

E-selectin is an adhesion molecule expressed on vascular endothelial cells in several inflammatory skin diseases, including psoriasis. It is responsible for the adherence between microvascular endothelium and neutrophils, monocytes, eosinophils and subsets of T cells. Soluble E-selectin (sE-selectin) serum levels were measured by ELISA in 32 psoriatic patients before treatment and compared with both post-treatment sE-selectin levels in 16 patients and sE-selectin values in 10 healthy individuals. Soluble E-selectin serum levels were significantly increased in psoriatic patients compared with healthy persons. Moreover, a significant correlation was demonstrated between sE-selectin values and PASI scores. No relationship was found between sE-selectin levels and duration of psoriasis. Soluble E-selectin serum levels decreased significantly after treatment of psoriasis. This phenomenon was more evident in patients with more severe psoriasis. In conclusion, sE-selectin serum levels correlate with the extent of psoriatic lesions and could be used as marker of the disease activity in psoriatic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233646     DOI: 10.1046/j.1365-2230.1999.00401.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease.

Authors:  H Sigmundsdóttir; J E Gudjónsson; I Jónsdóttir; B R Lúdvíksson; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

3.  Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis.

Authors:  Natalia Zdanowska; Agnieszka Owczarczyk-Saczonek; Joanna Czerwińska; Jacek J Nowakowski; Anna Kozera-Żywczyk; Witold Owczarek; Wojciech Zdanowski; Waldemar Placek
Journal:  Medicina (Kaunas)       Date:  2020-09-15       Impact factor: 2.430

4.  Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.

Authors:  Fan Bai; Wen Zheng; Yan Dong; Juan Wang; Malgorzata A Garstka; Ruilian Li; Jingang An; Huiqun Ma
Journal:  Oncotarget       Date:  2017-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.